- Home
- Publications
- Publication Search
- Publication Details
Title
Graft-versus-host disease
Authors
Keywords
-
Journal
CURRENT OPINION IN HEMATOLOGY
Volume 21, Issue 2, Pages 141-147
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-01-28
DOI
10.1097/moh.0000000000000026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
- (2013) C. Cutler et al. BLOOD
- Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease
- (2013) B. Xiao et al. BLOOD
- Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease
- (2013) Mehdi Hamadani et al. JOURNAL OF CLINICAL ONCOLOGY
- Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors
- (2013) Theresa Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future
- (2013) Ron Ram et al. LEUKEMIA & LYMPHOMA
- Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning
- (2012) Daniel Weisdorf et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
- (2012) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Regulation of acute graft-versus-host disease by microRNA-155
- (2012) P. Ranganathan et al. BLOOD
- Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity
- (2012) E. O. Stenger et al. BLOOD
- Response as an end point in treatment trials for acute GVHD
- (2012) S Z Pavletic BONE MARROW TRANSPLANTATION
- Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation
- (2012) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
- (2012) Ran Reshef et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303
- (2011) Steven M. Devine et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
- (2011) R. J. Soiffer et al. BLOOD
- Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
- (2011) G. Socie et al. BLOOD
- Novel treatment concepts for graft-versus-host disease
- (2011) D. Wolf et al. BLOOD
- Mouse models of graft-versus-host disease: advances and limitations
- (2011) M. A. Schroeder et al. Disease Models & Mechanisms
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis
- (2010) Janelle Perkins et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
- (2010) Daniel Wolff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
- (2010) L. Luznik et al. BLOOD
- Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
- (2009) Vincent T. Ho et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Imatinib for refractory chronic graft-versus-host disease with fibrotic features
- (2009) A. Olivieri et al. BLOOD
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
- (2009) Jürgen Finke et al. LANCET ONCOLOGY
- Treatment Change as a Predictor of Outcome among Patients with Classic Chronic Graft-versus-Host Disease
- (2008) Mary E.D. Flowers et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Sirolimus, Tacrolimus, and Low-Dose Methotrexate as Graft-versus-Host Disease Prophylaxis in Related and Unrelated Donor Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
- (2008) Edwin P. Alyea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation
- (2008) Mehdi Hamadani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
- (2008) M. Mielcarek et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started